Discover everything we can do at Konexio Biotech for your business related to human and/or veterinary medicines.
Module 1: ERA, PV System, RMP, Packaging Materials, and Readability Testing
Module 2: Experienced personnel with academic and professional training (MD, PhD)
Module 3: Quality
Module 4: Non-clinical
Module 5: Clinical
Discover the work process we follow at Konexio Biotech to shape your project in a comprehensive way.
We assess the applicable regulatory framework for the product, including the target region and the necessary classifications for compliance.
We design a clear and customized roadmap to meet the requirements of the competent authorities, optimizing time and resources.
We prepare technical and regulatory files, including modules on quality, safety, and efficacy, ready for submission to regulatory authorities.
We act as intermediaries with agencies like EMA or FDA, managing inquiries, clarification requests, and file updates.
We monitor and manage regulatory changes, license renewals, and necessary updates to maintain compliance after product approval.
We offer device classification, preparation of technical files, audit readiness, and support in obtaining the CE mark and other global approvals.
We act as a direct liaison with agencies such as the FDA, EMA, and local authorities, facilitating meetings, scientific consultations, and regulatory submissions.
We assist in the preparation and submission of Investigational New Drug (IND) applications and Clinical Trial Applications (CTA), ensuring compliance with the specific requirements of each region.
Yes, we have experience in regulatory registrations across the Americas, LATAM, Europe, Asia, and other emerging markets.
We monitor regulatory changes and help maintain compliance through timely updates to regulatory files and product documentation.
Yes, we ensure that labeling materials comply with national and international regulations and are clear for both patients and healthcare professionals.
We have worked with CAR-T, gene therapies, and orphan drugs, providing regulatory strategies tailored to these innovative technologies.
We evaluate the specific requirements for combination products and develop regulatory strategies that cover both the pharmaceutical component and the device.
Yes, we conduct internal and supplier audits to identify areas for improvement and ensure compliance with regulatory standards.
Yes, we prepare companies for inspections and assist them during and after the process to address any findings.